Thomas Civik
Förmögenhet: 587 998 $ per 2026-07-31
Förmögenhet: 587 998 $ per 2026-07-31
Thomas Civik is Chief Executive Officer & Director at Pyxis Oncology, Inc. since 2026 and Independent Chairman at Imcheck Therapeutics SAS since 2023.
Former roles include President, Chief Executive Officer & Director at Five Prime Therapeutics, Inc. from 2020 to 2021; Independent Chairman at Repare Therapeutics, Inc. from 2021 to 2026; Vice President-Avastin Sales & Marketing at Genentech, Inc. from 2000 to 2017; and Chief Commercial Officer at Foundation Medicine, Inc. from 2017 to 2019.
Education includes undergraduate studies at St. Norbert College, Inc. and an MBA from Kellogg School of Management.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
PYXIS ONCOLOGY, INC. 0,35 % | 2026-08-12 | 221 886 ( 0,35 % ) | 587 998 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Verkställande Direktör | 2026-02-03 |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Ordförande | 2023-03-23 |
| Företag | Position | Slut |
|---|---|---|
| REPARE THERAPEUTICS INC. | Ordförande | 2026-01-28 |
| FIVE PRIME THERAPEUTICS, INC. | Verkställande Direktör | 2021-04-16 |
| FOUNDATION MEDICINE INC | Företagsledare/Principal | 2019-09-01 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Försäljning & Marknadsföring | 2017-11-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
St. Norbert College, Inc.
St. Norbert College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foundation Medicine, Inc.
Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Health Technology |
Repare Therapeutics, Inc.
Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of novel cancer therapies | Health Technology |
Pyxis Oncology, Inc.
Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån